CBChristy Burden

Christy Burden

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christy Burden has a total of 206 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A systematic review of couple- or household-targeted interventions for smoking cessation in pregnancy

    by Sadie Mullin, Christy Burden, Kate Grant, Abi Merriel, Anna Davies

    Background: Tobacco smoking is a major modifiable risk for poor pregnancy outcomes. Pregnant women whose partner smokes are six times more likely to continue smoking. Typically, interventions target pregnant mothers or smoking fathers to reduce second-hand smoke exposure. Evidence reviews advocate for couple-targeted smoking cessation interventions, however no recent review has evaluated the effectiveness of interventions targeting both pregnant women and their partner/household member. We aimed to systematically review and evaluate the effectiveness of smoking cessation interventions targeting the couple/household where both parties smoke for antenatal smoking cessation in pregnant women. Methods: We searched 8 databases (MEDLINE, Embase, Emcare, AMED, BNI, CINAHL, PsycINFO, Cochrane Register of Controlled Trials) for randomised controlled trials (RCTs), controlled non-randomised studies and before-and-after studies, meeting PICO criteria: Population: pregnant woman and her partner/household member/s who are tobacco smokers antenatally. Intervention: Tobacco smoking cessation intervention targeting a couple/household. Control: Intervention targeting woman only, usual care, historical control group. Outcome/s: Objectively assessed or self-reported antenatal maternal smoking cessation. Studies were systematically selected for inclusion and data were extracted by two researchers. Meta-analysis was not undertaken due to clinical and methodological heterogeneity, including differing intervention types, outcome measures, cut-offs used to define cessation and follow-up timepoints. Data were narratively synthesised. Results: Six studies were included: 4 RCTs, 1 non-randomised comparative study and 1 before-and-after study. Interventions were poorly described, variable in content across studies, and differed in content between women and partners/household members within studies. They included behavioural support ( n = 6 women, n = 4 partners), written or self-help materials ( n = 4 women, n = 6 partners), nicotine replacement therapy ( n = 1 women, n = 1 partners), demonstration of smoking effects on the fetal heart ( n = 1 women) and incentives ( n = 1 women). Three studies directly targeted partners and three targeted them indirectly via the woman. Only one study compared targeting the couple versus the woman only. Varied subjective and objective cessation measures were assessed. Quit definition, measurement timepoint, and whether partner cessation was evaluated varied. Two RCTs, one non-randomised controlled and one before-and-after study reported that their intervention positively impacted smoking cessation for women compared with usual care. One RCT reported increased cessation for intervention versus control for partners. Conclusions: Few up-to-date studies have evaluated smoking cessation interventions targeting couples/households who smoke during pregnancy. Interventions rarely directly target partners. Interventions directly targeting the woman and her partner or smoking household members, using up-to-date interventions (e.g., nicotine replacement therapy, vapes, behavioural support) are yet to be assessed in high quality studies and more evidence in this field is needed. Standardised outcomes for both women and partners are needed to evaluate efficacy, identify the active components of interventions and facilitate evidence syntheses.


  • Open Access

    Variation in gestational diabetes diagnosis and care practices in maternity services in three high-income countries; a cross-sectional survey

    by Anna Davies, Amy Howell, Sharleen O’REilly, Helena Teede, Cheryce Harrison, Gemma Clayton, Fionnuala M. McAuliffe, Aisling Geraghty, Charlotte Williams, Christy Burden

    Background: There is limited international consensus about best diagnostic and care practices for gestational diabetes mellitus (GDM). This impacts consistency of care and perinatal outcomes. We aimed to explore GDM diagnostic and care practices in the UK, Ireland and Australia to better understand these variations and determine areas for improvement. Methods: We conducted a cross-sectional survey of healthcare professionals between August 2021-November 2022. The survey evaluated the use of GDM guidelines, associated diagnostic practices and post-diagnostic care. Data were descriptively analysed. Results: Sixty-three maternity centres were represented (35 England and Wales, 12 Ireland, 16 Australia). 94% of centres in England and Wales and Australia respectively used their national guidelines to select women for GDM testing, with a wider variety of guidelines used in Ireland. Over 80% of centres across countries test women for GDM based on risk-factors identified in early pregnancy. At 24–28 weeks’ gestation, 94% of Australian centres used universal screening as per national guidelines, compared with 3% of centres in England & Wales, and 50% in Ireland, where universal screening is not included in national guidelines. Risk factors used to select women for screening varied between countries and between centres within countries at both time points, with some centres using risk factors outside of their national guidelines. Diagnostic tests for GDM varied between countries and between centres within countries, and according to gestation and previous GDM. Insulin was the most common first-line treatment in Australia, whereas in Ireland and England and Wales it was Metformin. Birth was planned at differing gestations according to centre and country, and according to management strategy. Conclusions: GDM-related practices vary within and between Australia, Ireland and England and Wales. National guidelines are not adhered to in some centres, which could result in inconsistent care within countries, and could result in inequitable perinatal outcomes. Further research should address standardised, evidence-informed care and guideline implementation barriers.


  • Open Access

    Clinical and Behavioural Heterogeneity Among Women at Increased Risk for Gestational Diabetes: A Four-Country Analysis

    by Sharleen L. O’reilly, Ellen Greene, Fionnuala M. McAuliffe, Helena Teede, Cristina Campoy, Christy Burden, Aisling Geraghty, Mercedes G. Bermúdez, Anna Davies, Cheryce L. Harrison, et al.

    Gestational diabetes mellitus (GDM) is a growing global health concern due to its impact on maternal and infant health. GDM risk factors vary across populations, but international comparisons using standardised assessment tools are lacking. This study aimed to examine variations in risk factors, demographics and health behaviours among pregnant women at increased risk of GDM across four international sites and to investigate factors associated with maternal body mass index (BMI), a modifiable risk factor for GDM. This cross-sectional study included data from 804 pregnant women in Dublin (n = 213), Bristol (n = 205), Granada (n = 211) and Melbourne (n = 175) identified as having an increased risk of GDM, using the Monash GDM screening tool. Between-site differences were analysed using analysis of variance, Kruskal–Wallis and chi-square tests and factors associated with BMI at each site were examined using multiple linear regression. Despite standardised risk screening, significant heterogeneity was observed between sites in key GDM risk factors, including age (mean range 33.8–36.7 years), BMI (Melbourne 28.9 vs. Granada 26.9 kg/m2), physical activity (34.86–41.77 METs/week) and dietary intake (mean energy 1881–2136 kcal/day). Multiple factors were independently associated with BMI, including education level, ethnicity, health literacy and energy intake, with patterns varying by site. This study challenges the concept of a homogeneous “high-risk” GDM population by revealing substantial variations in risk factors and characteristics across different patient cohorts, highlighting the importance of developing context-sensitive approaches to GDM prevention.

  • Open Access

    A qualitative exploration of women’s expectations of birth and knowledge of birth interventions following antenatal education

    by Anna Davies, Michael Larkin, Lucy Willis, Narendra Mampitiya, Mary Lynch, Miriam Toolan, Abigail Fraser, Kate Rawling, Rachel Plachcinski, Sonia Barnfield, et al.

    Background: Expectations of birth, and whether they are met, influence postnatal psychological wellbeing. Intrapartum interventions, for example induction of labour, are increasing due to a changing pregnant population and evolving evidence, which may contribute to a mismatch between expectations and birth experience. NICE recommends antenatal education (ANE) to prepare women for labour and birth, but there is no mandated UK National Health Service (NHS) ANE curriculum. We aimed to explore women’s expectations of childbirth and their understanding of common interventions and complications following NHS and non-NHS ANE. Method: Qualitative focus groups were conducted with postnatal women (< 12 months postpartum) aged ≥ 16, who had received antenatal care at a single NHS Trust. A semi-structured topic guide was used to explore birth expectations following attendance at ANE and knowledge of birth interventions and complications. Data were transcribed and thematic analysis was undertaken by at least two researchers. Results: 46 women (mean age: 33.5years; 81% white British) participated across eight groups. 65% were primiparous, 35% had a caesarean birth. 50% attended NHS ANE and 59% non-NHS ANE. Participants perceived that a ‘hierarchy of birth’ was presented within ANE classes, where a ‘better birth’ involved vaginal birth, minimal pain relief and limited intervention. Participants described expectations of control and choice over their birth, though some described being encouraged to be open-minded about the course it may take. Participants identified a mismatch between their expectations and subsequent experiences, which adversely impacted their psychological wellbeing. While participants received information about common birth interventions and complications, limited time spent on these during classes resulted in expectations that they were rare. Participants felt that receiving sensitively presented information about the frequency of interventions could prepare women and support their psychological wellbeing after birth. Conclusions: Women’s expectations of birth are informed by ANE which may precipitate a mismatch between expectations and experience. Better information about risk factors and frequency of labour and birth interventions may support women to develop evidence-informed expectations of birth, reducing the expectation-experience gap, with consequent impact on maternal postnatal wellbeing. A mandatory minimum curriculum for ANE is needed to ensure high-quality education is available to all.


  • Open Access

    Assessing the benefits and risks to mothers and offspring of continuing treatment for maternal hypertension and hypothyroidism: an observational cohort study in the UK Clinical Practice Research Datalink

    by Ciarrah-Jane S Barry, Venexia M Walker, Christy Burden, George Davey Smith, Neil M Davies

    Exclusion of pregnant women from clinical trials, due to ethical concerns, has limited evidence on medication safety during pregnancy, resulting in conservative guidance. Yet, rising prevalence of chronic conditions in reproductive-age women has increased medication use. This study evaluates risks and benefits of discontinuing drug prescriptions for chronic hypertension, and hypothyroidism during pregnancy using linked primary care records from a longitudinal intergenerational database. Using UK Clinical Practice Research Datalink (CPRD) GOLD, we conducted multivariable regression models, adjusted for covariates, to assess maternal treatment discontinuation on various outcomes. Cohorts of 3,232 and 3,334 pregnancies with chronic hypertension and hypothyroidism respectively were derived from the CPRD. Discontinuing vasodilator antihypertensive drugs for hypertension was associated with increased gestational age (mean difference: 3.98 weeks, 95% CI: 1.61, 6.35). Estimated associations between other antihypertensives (calcium-channel blockers, diuretics or renin-angiotensin system drugs) and any study outcome crossed the null. Discontinuing thyroid hormones for hypothyroidism were associated with reduced the odds of miscarriage (OR: 0.29, 95% CI: 0.15, 0.54) and increased gestational age (mean difference 1.84 weeks, 95% CI: 0.12, 3.57). Results were robust in sensitivity analysis. This study reports a reassuring lack of association between many drug subclasses and adverse offspring outcomes. This evidence of potential risk associated with treatment discontinuation may guide clinical decision-making for treating chronic hypertension and hypothyroidism during pregnancy in similar populations.

  • Open Access

    Protocol for a mixed-methods study to develop a Core Outcome Set for assessing interventions and care for parents after neonatal death (iCHOOSE Neonatal study)

    by Anna Davies, Charlotte Williams, Christy Burden, Sadie Mullin, Lucy Moy, Maggie Redshaw, Mehali Patel, Abigail Fraser, Lisa Hinton, Mary Lynch, et al.

    Introduction: Neonatal death exerts long lasting impact on parents’ mental health, finances and relationships, and the wider family. There is national and international momentum to evaluate interventions to support parents after the death of a baby. Core Outcome Sets provide a minimum set of outcomes, agreed by stakeholders to be important, that should be evaluated in all studies to support evidence syntheses and identification of the most effective interventions. Aim: We aim to develop a Core Outcome Set (COS) for assessing interventions and care after neonatal death, to support future evidence syntheses and enable identification of effective interventions and care for parents. Methods and analysis: We will develop the COS in 6 phases. A parent involvement group and stakeholder steering committee have been established and have informed each planned phase: 1) Systematic review of quantitative studies evaluating care and interventions provided after neonatal death, to describe interventions, outcomes, and outcome measurement tools used to assess intervention effectiveness; 2) Qualitative interviews with parents who have experienced neonatal death to identify outcomes important and relevant to them; 3) Think-Aloud interviews with stakeholders (bereaved parents and professionals) to develop and refine an online survey; 4) Real-Time online international Delphi survey with bereaved parents and professionals to shortlist outcomes for consideration in the COS; 5) Adapted nominal group online consensus meetings with parents and professionals to agree final COS; 6) Identification of a preliminary set of measurement tools. Ethics and dissemination: Ethical approval has been granted for all activities to be undertaken by the University of Bristol Health Sciences Faculty Research Ethics Committee (reference: 15121). We will disseminate the findings via peer-reviewed publications and relevant academic and professional conferences. Registration: This COS has been registered on the COMET database.(1) The systematic review has been registered on the PROSPERO database (CRD42020151365)

  • Open Access

    Maternal haemoglobin levels and adverse pregnancy outcomes: individual patient data analysis from two prospective UK pregnancy cohorts

    by Christy Burden, Gordon Smith, Ulla Sovio, Gemma Clayton, Abigail Fraser

    Objective To estimate the shape and magnitude of associations between maternal Hb levels in the first and third trimesters of pregnancy, and pregnancy outcomes in a high-income setting. Design Prospective cohort studies Setting Two population based pregnancy cohorts from the UK Population The Avon Longitudinal Study of Parents and Children(ALSPAC) and Pregnancy Outcome Prediction Study(POPS). Methods We used multivariable logistic regression models to examine the relationship between Hb and pregnancy outcomes, adjusting for maternal age, ethnicity, BMI, smoking status and parity. Main Outcome Measures Preterm labour, low birth weight, small for gestational age(SGA), pre-eclampsia(PET), and gestational diabetes mellitus(GDM). Results There was no strong evidence of associations between a higher Hb (1g/dL) in the first trimester and preterm birth (1.07: 95% CI 0.96,1.21), low birth weight(1.09: 0.96, 1.24) and SGA (1.05; 0.96, 1.14). Higher Hb in the third trimester was associated with preterm birth (1.43:1.28,1.61), low birth weight(1.68: 1.48,1.90) and SGA (1.41:1.30, 1.53). Higher Hb in the first and third trimesters were associated with PET in ALSPAC(1st trimester- 1.38:1.07,1.76, 3rd trimester- 1.57: 1.28,1.94) but not in POPS(1st trimester- 1.10: 0.92, 1.30, 3rd trimester- 1.10: 0.92, 1.31). In ALSPAC(1st trimester- 1.37:0.96,1.95, 3rd trimester- 1.35:0.97,1.78) and POPS(1st trimester- 0.94:0.77, 1.17, 3rd trimester- 0.85: 0.69, 1.01), there were no associations with GDM. Conclusion Higher maternal Hb, in late pregnancy, may indicate a suboptimal increase in blood volume and therefore, women at risk of adverse pregnancy outcomes. Further research is required to investigate if this association is causal, and to identify underlying mechanisms.

  • Open Access

    Co-design and refinement of an optimised antenatal education session to better inform women and prepare them for labour and birth

    by Abi Merriel, Miriam Toolan, Mary Lynch, Gemma Louise Clayton, Andrew Demetri, Lucy Willis, Narendra Mampitiya, Alice Clarke, Katherine Birchenall, Chloe de Souza, et al.

    Objective: To co-design, implement, evaluate acceptability and refine an optimised antenatal education session to improve birth preparedness. Design: There were four distinct phases: co-design (focus groups and co-design workshops with parents and staff); implementation of intervention; evaluation (interviews, questionnaires, structured feedback forms), and systematic refinement. Setting: A single maternity unit with approximately 5,500 births annually. Participants: Postnatal and antenatal women/birthing people, birth partners and clinicians. Outcome measures: To establish whether the optimised session is deliverable, acceptable, meets the needs of women/birthing people and partners, and refine it with input from parents, clinicians and researchers. Results: The co-design was undertaken by 35 women, partners and clinicians. Five midwives were trained and delivered 19 Antenatal education (ACE) sessions to 142 women and 94 partners. 121 women and 33 birth partners completed the feedback questionnaire. Women/birthing people(79%) and birth partners(82%) felt more prepared after the class with most participants finding the content very helpful or helpful. Women/birthing people perceived classes were more useful and engaging than their partners. Interviews with 21 parents, a midwife focus group and a structured feedback form resulted in 38 recommended changes: 22 by parents, 5 by midwives and 11 by both. Suggested changes have been incorporated in the training resources to achieve an optimised intervention. Conclusions: Engaging stakeholders (women and staff) in co-designing an evidence informed curriculum resulted in an antenatal class designed to improve preparedness for birth, including assisted birth, that is acceptable to women and their birthing partners, and has been refined to address feedback and is deliverable within NHS resource constraints. A nationally-mandated antenatal education curriculum is needed to ensure parents receive high-quality antenatal education that targets birth preparedness. Key messages: What is already known: Antenatal education is used to prepare women/birthing parents for labour, birth and the postnatal period, but it has been eroded. Antenatal education has potential to support women/birthing parents in developing their expectations around labour and the postnatal period, via improved health literacy. Improving antenatal education could be impactful as the expectation-experience gap is linked to post traumatic stress disorder. What this study adds: We have shown that a co-designed, optimised antenatal class can provide information helpful to parents and important to staff, within the constraints of the NHS resources How this study might affect research, practice or policy: This study can be used to understand what parents need from antenatal education, and how to begin to address the expectation-experience gap.


  • Open Access

    Impact of COVID‐19 on gestational diabetes pregnancy outcomes in the UK: A multicentre retrospective cohort study

    by Niamh‐Maire Mclennan, Robert Lindsay, Ponnusamy Saravanan, Nithya Sukumar, Sara L. White, Peter von Dadelszen, Christy Burden, Kathryn Hunt, Priya George, Jane E. Hirst, et al.

    Objective: To determine the impact of implementing emergency care pathway(s) for screening, diagnosing and managing women with gestational diabetes (GDM) during COVID‐19.Design: Retrospective multicentre cohort.Setting: Nine National Health Service (NHS) Hospital Trusts/Health boards in England and Scotland.Population: 4915 women with GDM pre‐pandemic (1 April 2018 to 31 March 2020), and 3467 women with GDM during the pandemic (1 May 2020 to 31 March 2021).Methods: We examined clinical outcomes for women with GDM prior to and during the pandemic following changes in screening methods, diagnostic testing, glucose thresholds and introduction of virtual care for monitoring of antenatal glycaemia.Main Outcome Measures: Intervention at birth, perinatal mortality, large‐for‐gestational‐age infants and neonatal unit admission.Results: The new diagnostic criteria more often identified GDM women who were multiparous, had higher body mass index (BMI) and greater deprivation, and less frequently had previous GDM (all p < 0.05). During COVID, these women had no differences in the key outcome measures. Of the women, 3% were identified with pre‐existing diabetes at antenatal booking. Where OGTT continued during COVID, but virtual care was introduced, outcomes were also similar pre‐ and during the pandemic.Conclusions: Using HbA1c and fasting glucose identified a higher risk GDM population during the pandemic but this had minimal impact on pregnancy outcomes. The high prevalence of undiagnosed pre‐existing diabetes suggests that women with GDM risk factors should be offered HbA1c screening in early pregnancy.


  • Open Access

    Protocol for a multi-site randomised controlled feasibility study investigating intermittently scanned blood continuous glucose monitoring use for gestational diabetes: the RECOGNISE study

    by Anna Davies, Erik Lenguerrand, Eleanor Scott, Rebecca Kandiyali, Isabelle Douek, Jane Norman, Abi Loose, Lynn Sawyer, Laura Timlin, Christy Burden

    Background: Incidence of gestational diabetes mellitus (GDM) is increasing and is associated with adverse perinatal outcomes including macrosomia, pre-eclampsia, and pre-term delivery. Optimum glycaemic control can reduce these adverse perinatal outcomes. Continuous glucose monitoring (CGM) informs users about interstitial glucose levels allowing early detection of glycaemic excursions and pharmacological or behavioural intervention. Few adequately powered RCTs to evaluate the impact of using CGM in women with GDM on perinatal outcomes have been undertaken.We aim to establish the feasibility of a multi-site RCT to evaluate the clinical- and cost-effectiveness of an intermittently scanned continuous glucose monitor (isCGM) compared with self-monitored blood glucose (SMBG) in women with GDM for reducing fetal macrosomia and improving maternal and fetal outcomes. We will evaluate recruitment and retention rates, adherence to device requirements, adequacy of data capture and acceptability of trial design and isCGM devices.Methods: Open-label multicentre randomised controlled feasibility trial. Inclusion criteria: pregnant women, singleton pregnancy, recent diagnosis of GDM (within 14 days of commencing medication, up to 34 weeks gestation) prescribed metformin and/or insulin. Women will be consecutively recruited and randomised to isCGM (FreestyleLibre2) or SMBG. At every antenatal visit, glucose measurements will be evaluated. The SMBG group will use blinded isCGM for 14 days at baseline (~ 12–32 weeks) and ~ 34–36 weeks. The primary outcome is the recruitment rate and absolute number of women participating. Clinical assessments of maternal and fetal/infant health will be undertaken at baseline, birth, up to ~ 13 weeks post-natal. Psychological, behavioural and health economic measures will be assessed at baseline and ~ 34–36 weeks gestation. Qualitative interviews will be undertaken with study decliners, participants, and professionals to explore trial acceptability, of using isCGM and SMBG.Discussion: GDM can be associated with adverse pregnancy outcomes. isCGM could offer a timely, easy-to-engage-with intervention, to improve glycaemic control, potentially reducing adverse pregnancy, birth and long-term health outcomes for mother and child. This study will determine the feasibility of conducting a large-scale multisite RCT of isCGM in women with GDM.Trial registration: This study has been registered with the ISRCTN (reference:ISRCTN42125256, Date registered: 07/11/2022).